Ronald E Blaylock
Insider (Form 4 reporting owner): Director CIK 1214686Name as filed: BLAYLOCK RONALD EIts filings on EDGARAll insiders
Measures activity, not value. Not investment advice.
Since 13 Jul 2020, sold $2.6M in 2 sales and bought $2.0M in 3 open-market purchases across 2 companies.
Companies
Role on the latest Form 4 for each; open-market trades countedWhat the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.
Median return minus the sector fund, in percentage points; "too few trades" under 5| Open-market trades | After 3 months | After 6 months | After 12 months |
|---|---|---|---|
| After purchases | too few trades3 trades | too few trades2 trades | too few trades2 trades |
| After sales | too few trades2 trades | too few trades2 trades | too few trades2 trades |
For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.
By year
Counted open-market trades, by trade date| Year | Purchases | Bought | Sales | Sold | Net |
|---|---|---|---|---|---|
| 2026 | 1 | $999K | – | – | $999K |
| 2025 | 1 | $499K | – | – | $499K |
| 2021 | – | – | 1 | $1.7M | -$1.7M |
| 2020 | 1 | $501K | 1 | $912K | -$410K |
Every trade
5, newest first; open-market purchases and sales only| Trade date | Company | Side | Shares | Price | Value | Planned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. | Filing |
|---|---|---|---|---|---|---|---|
| 5 Aug 2026 | Pfizer PFE | Buy | 39,231 | $25.46 | $999K | No | Form 4filed 5 Aug 2026 |
| 13 Feb 2025 | Pfizer PFE | Buy | 19,457 | $25.65 | $499K | No | Form 4filed 14 Feb 2025 |
| 16 Jul 2021 | CarMax KMX | Sell | 12,500 | $132.02 | $1.7M | Not stated | Form 4filed 20 Jul 2021 |
| 6 Aug 2020 | Pfizer PFE | Buy | 13,000 | $38.55 | $501K | Not stated | Form 4filed 10 Aug 2020 |
| 13 Jul 2020 | CarMax KMX | Sell | 10,200 | $89.37 | $912K | Not stated | Form 4filed 15 Jul 2020 |
From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.